WHEN TAMOXIFEN TURNS BAD

被引：35

作者：

HORWITZ, KB

机构：

来源：

ENDOCRINOLOGY | 1995年 / 136卷 / 03期

关键词：

D O I：

10.1210/en.136.3.821

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：821 / 823

页数：3

共 25 条

[1]

ASTRUC ME, ENDOCRINOLOGY, V136, P824

[2]

CATHERINO WH, 1994, 17TH ANN SAN ANT BRE, P32

[3]

EBCTC Group, 1992, LANCET, V339, P1

[4] MEASUREMENT OF STEROID-HORMONE RECEPTORS IN BREAST-CANCER PATIENTS ON TAMOXIFEN [J].

ENCARNACION, CA ;

CIOCCA, DR ;

MCGUIRE, WL ;

CLARK, GM ;

FUQUA, SAW ;

OSBORNE, CK .

BREAST CANCER RESEARCH AND TREATMENT, 1993, 26 (03) :237-246

[5]

EPSTEIN S, 1992, NEW ENGL J MED, V326, P852

[6] ALTERATION IN THE AGONIST/ANTAGONIST BALANCE OF ANTIESTROGENS BY ACTIVATION OF PROTEIN-KINASE A SIGNALING PATHWAYS IN BREAST-CANCER CELLS - ANTIESTROGEN SELECTIVITY AND PROMOTER DEPENDENCE [J].

FUJIMOTO, N ;

KATZENELLENBOGEN, BS .

MOLECULAR ENDOCRINOLOGY, 1994, 8 (03) :296-304

[7]

FUQUA SAW, 1993, BREAST CANCER RES TR, V26

[8] ACTIVATION OF THE OVALBUMIN GENE BY THE ESTROGEN-RECEPTOR INVOLVES THE FOS-JUN COMPLEX [J].

GAUB, MP ;

BELLARD, M ;

SCHEUER, I ;

CHAMBON, P ;

SASSONECORSI, P .

CELL, 1990, 63 (06) :1267-1276

[9]

GOTTARDIS MM, 1988, CANCER RES, V48, P5183

[10]

GRAHAM ML, 1992, CANCER RES, V52, P593

← 1 2 3 →